| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.7 / 5 (353 reviews) | Istanbul, Turkey | 37+ years | Ocrevus (ocrelizumab) | Relapsing-remitting multiple sclerosis | JCI-accredited hospital with specialized neurology department and a 90% success rate for organ transplants. Offers comprehensive diagnostic tests before starting treatment. | International Organization for Standardization, Joint Commission International | ||
| #2 | 4.5 / 5 (0 reviews) | Madrid, Spain | — | — | Ocrevus (ocrelizumab) | — | — | Joint Commission International , International Organization for Standardization | |
| #3 | 4.6 / 5 (473 reviews) | Istanbul, Turkey | — | — | Ocrevus (ocrelizumab) | Demyelinating diseases | Offers Ocrevus for modern treatment of demyelinating diseases. JCI-accredited facility with specialized neurology department and comprehensive pre-treatment diagnostics. | Joint Commission International , Patient choice in Pediatric Oncology & Hematology Oncology | |
| #4 | 5.0 / 5 (1 review) | Lugano, Switzerland | — | — | Ocrevus (ocrelizumab) | — | — | Given to the doctor International Society of Aesthetic Plastic Surgery (ISAPS) Сertificate | |
| #5 | 4.7 / 5 (438 reviews) | Barcelona, Spain | — | 23,000+ treatments | Ocrevus (ocrelizumab) infusion, pre-infusion testing, hepatitis B screening | Relapsing-remitting multiple sclerosis (RRMS) | Offers Ocrevus infusions supervised by Dr. Anna Pujol, a neurologist specialized in MS. Includes pre-infusion testing and post-infusion observation. JCI-accredited with 95% patient recommendation rate. | Joint Commission International , European Foundation for Quality Management | |
| #6 | 4.5 / 5 (155 reviews) | Tel Aviv, Israel | 41+ years34,000+ treatments | Ocrevus (ocrelizumab) infusion, MAVENCLAD oral therapy | Relapsing and primary progressive MS | JCI-accredited center with a neuroimmunology clinic led by Professor Arnon Karni, an MS specialist trained at Harvard. Uses FDA-approved Ocrevus with a 24% reduction in disability progression risk at 12 weeks versus placebo. | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek | ||
| #7 | 4.6 / 5 (126 reviews) | Antalya , Turkey | — | — | Ocrevus (ocrelizumab), targeted therapy | Multiple sclerosis management | Follows NCCN and ESMO protocols for neurological conditions. JCI-accredited hospital with dedicated neurology department and international patient services. | Joint Commission International | |
| #8 | 4.5 / 5 (51 reviews) | Istanbul, Turkey | 22+ years | EEG (Electroencephalography), CT (computer tomography) | — | — | Joint Commission International | ||
| #9 | 4.6 / 5 (514 reviews) | Istanbul, Turkey | — | — | Revision of MRI results, Brain MRI | — | — | International Organization for Standardization, Joint Commission International | |
| #10 | 4.7 / 5 (131 reviews) | Istanbul, Turkey | — | — | Ocrevus (ocrelizumab), brain MRI, blood tests | Multiple sclerosis treatment | Specializes in neurology with advanced diagnostics. Offers comprehensive MS treatment including Ocrevus. 91% patient recommendation rate. | International Organization for Standardization, Joint Commission International |